CGS-8216
Chemical compound
| CGS-8216 | |
|---|---|
| [[File:|frameless|220px|alt=|]] | |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
CGS-8216 is a chemical compound that acts as a benzodiazepine receptor antagonist. It is known for its ability to counteract the effects of benzodiazepines, which are a class of drugs primarily used for treating anxiety, insomnia, and several other conditions.
Pharmacology
CGS-8216 binds to the GABA A receptor at the same site as benzodiazepines but does not activate the receptor. Instead, it blocks the effects of benzodiazepines, making it useful in research to study the role of GABA A receptors in various physiological and pathological processes.
Mechanism of Action
The primary mechanism of action of CGS-8216 involves its interaction with the GABA A receptor. By binding to the benzodiazepine site on the receptor, CGS-8216 prevents benzodiazepines from exerting their effects, which include sedation, anxiolysis, and muscle relaxation. This makes CGS-8216 a valuable tool in the study of GABAergic neurotransmission.
Research Applications
CGS-8216 is widely used in neuroscience research to investigate the role of GABA A receptors in the central nervous system. It has been employed in studies examining the effects of benzodiazepines on memory, anxiety, and seizures. Additionally, CGS-8216 has been used to explore the potential therapeutic applications of benzodiazepine receptor antagonists in conditions such as benzodiazepine overdose and dependence.
Safety and Toxicity
As with many research chemicals, the safety and toxicity profile of CGS-8216 is not fully understood. It is primarily used in controlled laboratory settings, and its effects in humans have not been extensively studied. Researchers handling CGS-8216 should follow appropriate safety protocols to minimize any potential risks.
See also
References
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD